Patents by Inventor Zachary Abbott

Zachary Abbott has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240316123
    Abstract: Provided herein are recombinant microorganisms that express a subject polypeptide. Microorganisms can comprise an expression construct comprising a flagellin promoter operatively linked with a heterologous nucleotide sequence encoding the subject polypeptide. The flagellin promoter sequence can comprise a genetic modification that reduces CsrA inhibition of translation. Microorganisms also can comprise a genetic modification that reduces FlgM inhibition of SigD initiation of transcription. The target polypeptide can be an aldehyde dehydrogenase. Such microorganisms are useful in the treatment of alcohol hangover.
    Type: Application
    Filed: March 26, 2024
    Publication date: September 26, 2024
    Inventor: Zachary Abbott
  • Patent number: 11975033
    Abstract: Provided herein are recombinant microorganisms that express a subject polypeptide. Microorganisms can comprise an expression construct comprising a flagellin promoter operatively linked with a heterologous nucleotide sequence encoding the subject polypeptide. The flagellin promoter sequence can comprise a genetic modification that reduces CsrA inhibition of translation. Microorganisms also can comprise a genetic modification that reduces FlgM inhibition of SigD initiation of transcription. The target polypeptide can be an aldehyde dehydrogenase. Such microorganisms are useful in the treatment of alcohol hangover.
    Type: Grant
    Filed: October 26, 2020
    Date of Patent: May 7, 2024
    Assignee: ZBiotics Company
    Inventor: Zachary Abbott
  • Patent number: 11696932
    Abstract: Provided herein are recombinant microorganisms that express a subject polypeptide. Microorganisms can comprise an expression construct comprising a flagellin promoter operatively linked with a heterologous nucleotide sequence encoding the subject polypeptide. The flagellin promoter sequence can comprise a genetic modification that reduces CsrA inhibition of translation. Microorganisms also can comprise a genetic modification that reduces FlgM inhibition of SigD initiation of transcription. The target polypeptide can be an aldehyde dehydrogenase. Such microorganisms are useful in the treatment of alcohol hangover.
    Type: Grant
    Filed: September 13, 2018
    Date of Patent: July 11, 2023
    Assignee: ZBiotics Company
    Inventor: Zachary Abbott
  • Publication number: 20210121506
    Abstract: Provided herein are recombinant microorganisms that express a subject polypeptide. Microorganisms can comprise an expression construct comprising a flagellin promoter operatively linked with a heterologous nucleotide sequence encoding the subject polypeptide. The flagellin promoter sequence can comprise a genetic modification that reduces CsrA inhibition of translation. Microorganisms also can comprise a genetic modification that reduces FlgM inhibition of SigD initiation of transcription. The target polypeptide can be an aldehyde dehydrogenase. Such microorganisms are useful in the treatment of alcohol hangover.
    Type: Application
    Filed: October 26, 2020
    Publication date: April 29, 2021
    Inventor: Zachary Abbott
  • Patent number: 10849938
    Abstract: Provided herein are recombinant microorganisms that express a subject polypeptide. Microorganisms can comprise an expression construct comprising a flagellin promoter operatively linked with a heterologous nucleotide sequence encoding the subject polypeptide. The flagellin promoter sequence can comprise a genetic modification that reduces CsrA inhibition of translation. Microorganisms also can comprise a genetic modification that reduces FlgM inhibition of SigD initiation of transcription. The target polypeptide can be an aldehyde dehydrogenase. Such microorganisms are useful in the treatment of alcohol hangover.
    Type: Grant
    Filed: July 27, 2018
    Date of Patent: December 1, 2020
    Assignee: ZBiotics Company
    Inventor: Zachary Abbott
  • Publication number: 20200345793
    Abstract: Provided herein are recombinant microorganisms that express a subject polypeptide. Microorganisms can comprise an expression construct comprising a flagellin promoter operatively linked with a heterologous nucleotide sequence encoding the subject polypeptide. The flagellin promoter sequence can comprise a genetic modification that reduces CsrA inhibition of translation. Microorganisms also can comprise a genetic modification that reduces FlgM inhibition of SigD initiation of transcription. The target polypeptide can be an aldehyde dehydrogenase. Such microorganisms are useful in the treatment of alcohol hangover.
    Type: Application
    Filed: September 13, 2018
    Publication date: November 5, 2020
    Inventor: Zachary ABBOTT
  • Publication number: 20190076489
    Abstract: Provided herein are recombinant microorganisms that express a subject polypeptide. Microorganisms can comprise an expression construct comprising a flagellin promoter operatively linked with a heterologous nucleotide sequence encoding the subject polypeptide. The flagellin promoter sequence can comprise a genetic modification that reduces CsrA inhibition of translation. Microorganisms also can comprise a genetic modification that reduces FlgM inhibition of SigD initiation of transcription. The target polypeptide can be an aldehyde dehydrogenase. Such microorganisms are useful in the treatment of alcohol hangover.
    Type: Application
    Filed: July 27, 2018
    Publication date: March 14, 2019
    Inventor: Zachary ABBOTT
  • Patent number: 10118520
    Abstract: A vehicle seat assembly comprises a seat bottom having a bottom cushion, a seat back coupled to the seat bottom with the seat back having a back cushion, and at least one of the bottom cushion and the back cushion having a passage. The assembly further includes a flow control layer coupled to the cushion having the passage with the flow control layer defining a first support area having a first plurality of slits and a second support area, adjacent to the first support area, having a second plurality of slits. Each slit defines a width that is moveable between a restricted position and a free-flowing position. The width of the first slits can move to the free-flowing position while the width of the second slits remains in the restricted position when the first support area receives a first load for flowing air through the first slits and the passage.
    Type: Grant
    Filed: June 16, 2016
    Date of Patent: November 6, 2018
    Assignee: Kongsberg Automotive, Inc.
    Inventors: Benjamin Craig, Zachary Abbott, Robert Case, Douglas Wheeler
  • Publication number: 20170361742
    Abstract: A vehicle seat assembly comprises a seat bottom having a bottom cushion, a seat back coupled to the seat bottom with the seat back having a back cushion, and at least one of the bottom cushion and the back cushion having a passage. The assembly further includes a flow control layer coupled to the cushion having the passage with the flow control layer defining a first support area having a first plurality of slits and a second support area, adjacent to the first support area, having a second plurality of slits. Each slit defines a width that is moveable between a restricted position and a free-flowing position. The width of the first slits can move to the free-flowing position while the width of the second slits remains in the restricted position when the first support area receives a first load for flowing air through the first slits and the passage.
    Type: Application
    Filed: June 16, 2016
    Publication date: December 21, 2017
    Inventors: Benjamin Craig, Zachary Abbott, Robert Case, Douglas Wheeler